Omeros nets $32.3 million for surgical drugs
This article was originally published in Scrip
Executive Summary
Omeros earned net proceeds of $32.3 million in a common stock offering of 3.4 million shares priced at $10.25 per share that closed on 2 July. The Seattle, Washington-based company generated $4.2 million above the net gain anticipated when the offering went to market on 27 June, because all 439,024 shares granted to the underwriters to cover overallotments were sold.